About Acuta Capital
Acuta Capital Partners is a healthcare-focused investment firm that primarily backs publicly listed and late-stage biotechnology companies. The firm concentrates on structured and post-IPO equity financings within the life sciences sector.
Acuta's activity is heavily weighted toward post-IPO equity rounds, providing growth capital to clinical- and commercial-stage biotech companies.
Notable investments include Surrozen, Aadi Bioscience, Enliven Therapeutics, Ocular Therapeutix, Tourmaline Bio, Taysha Gene Therapies, BioAtla, and Ventyx Biosciences.
People
- Scott Smith, Chief Operating Officer
You last contacted this investor on .